The impact of parental postpartum pertussis vaccination on infection in infants: A population-based study of cocooning in Western Australia
MetadataShow full item record
During a pertussis epidemic in 2011–2012 the Western Australian (WA) Department of Health implemented a ‘cocooning’ programme, offering free pertussis-containing vaccine (dTpa) to new parents. We assessed the impact of vaccinating parents with dTpa on the incidence of pertussis infection in newborns. Births in WA during 2011–2012 were linked to a register of parental pertussis vaccinations and to notified reports of laboratory-proven pertussis in children <6 months of age. Parents who received dTpa during the four weeks after their child's birth were defined as ‘vaccinated postpartum.’ Cox proportional-hazards methods were used to calculate hazard ratios (HRs) and 95% confidence intervals (CIs) for the risk of pertussis infection among infants born to parents vaccinated postpartum vs. unvaccinated parents, adjusted for maternal age, geographic region, timing of birth, and number of siblings. Of 64,364 live-births, 43,480 (68%) infants had at least one vaccinated parent (60% of mothers and 36% of fathers). After excluding records where parent(s) were either vaccinated prior to the birth, vaccinated >28 days after the birth, the vaccination date was uncertain, or the child died at birth (n = 42), the final cohort contained 53,149 children, 118 of whom developed pertussis. There was no difference in the incidence of pertussis among infants whose parents were both vaccinated postpartum compared to those with unvaccinated parents (1.9 vs 2.2 infections per 1000 infants; adjusted HR 0.91; 95%CI 0.55–1.53). Similarly, when assessed independently, maternal postpartum vaccination was not protective (adjusted HR 1.19; 95%CI 0.82–1.72). Supplemental sensitivity analyses which varied the time period for parental vaccination and accounted for under-reporting of vaccination status did not significantly alter these findings. In our setting, vaccinating parents with dTpa during the four weeks following delivery did not reduce pertussis diagnoses in infants. WA now provides dTpa vaccine to pregnant women during the third trimester.
Showing items related by title, author, creator and subject.
A prospective cohort study assessing the reactogenicity of pertussis and influenza vaccines administered during pregnancyRegan, Annette; Tracey, L.; Blyth, C.; Richmond, P.; Effler, P. (2016)BACKGROUND: Pertussis vaccination during pregnancy can prevent 91% of infant infections. In 2015, antenatal pertussis vaccination programs were introduced across Australia. METHODS: To monitor the safety of this program, ...
Links2HealthierBubs' cohort study: Protocol for a record linkage study on the safety, uptake and effectiveness of influenza and pertussis vaccines among pregnant Australian womenSarna, Minda ; Andrews, R.; Moore, H.; Binks, M.J.; Mchugh, L.; Pereira, Gavin ; Blyth, C.C.; Van Buynder, P.; Lust, K.; Effler, P.; Lambert, S.B.; Omer, S.B.; Mak, D.B.; Snelling, Tom ; D'antoine, H.A.; Mcintyre, P.; De Klerk, N.; Foo, D.; Regan, Annette (2019)Introduction Pregnant women and infants are at risk of severe influenza and pertussis infection. Inactivated influenza vaccine (IIV) and diphtheria-tetanus-acellular pertussis vaccine (dTpa) are recommended during pregnancy ...
Lotter, K.; Regan, Annette; Thomas, T.; Effler, P.; Mak, D. (2017)© 2017 ANZJOG. Background: Antenatal influenza and pertussis vaccination prevent serious disease in mothers and infants. Aboriginal individuals are at increased risk of infection yet little is known about vaccine coverage ...